Standout Papers

Prediction of Coronary Heart Disease Using Risk Factor Categories 1998 2026 2007 2016 6.9k
  1. Prediction of Coronary Heart Disease Using Risk Factor Categories (1998)
    Peter W.F. Wilson, Ralph B. D’Agostino et al. Circulation
  2. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
    Neil J. Stone, Jennifer G. Robinson et al. Circulation
  3. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (2013)
    David C. Goff, Donald M. Lloyd‐Jones et al. Journal of the American College of Cardiology
  4. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
    Neil J. Stone, Jennifer G. Robinson et al. Journal of the American College of Cardiology
  5. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease (2003)
    Mark J. Sarnak, Andrew S. Levey et al. Circulation
  6. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (2013)
    David C. Goff, Donald M. Lloyd‐Jones et al. Circulation
  7. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease (2002)
    Sudha Seshadri, Alexa Beiser et al. New England Journal of Medicine
  8. Forecasting the Future of Cardiovascular Disease in the United States (2011)
    Paul A. Heidenreich, Justin G. Trogdon et al. Circulation
  9. Obesity and the Risk of Heart Failure (2002)
    Satish Kenchaiah, Jane C. Evans et al. New England Journal of Medicine
  10. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. (1986)
    William P. Castelli, Robert J. Garrison et al. PubMed
  11. Cardiovascular disease risk profiles (1991)
    Keaven M. Anderson, Patricia M. Odell et al. American Heart Journal
  12. Validation of the Framingham Coronary Heart Disease Prediction Scores (2001)
    Ralph B. D’Agostino, Scott M. Grundy et al. JAMA
  13. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus (2005)
    Peter W.F. Wilson, Ralph B. D’Agostino et al. Circulation
  14. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. (1994)
    Andrew A. Guccione, David T. Felson et al. American Journal of Public Health
  15. Obesity and Systemic Oxidative Stress (2003)
    John F. Keaney, Martin G. Larson et al. Arteriosclerosis Thrombosis and Vascular Biology
  16. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis (2007)
    Philippe Gabríel Steg, Deepak L. Bhatt et al. JAMA
  17. Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis (1995)
    Jacob Selhub, Paul F. Jacques et al. New England Journal of Medicine
  18. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age (2006)
    Donald M. Lloyd‐Jones, Eric Leip et al. Circulation
  19. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease (2003)
    Mark J. Sarnak, Andrew S. Levey et al. Hypertension
  20. Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons (1994)
    Clark T. Sawin, Andrew S. Geller et al. New England Journal of Medicine
  21. Criteria for Evaluation of Novel Markers of Cardiovascular Risk (2009)
    Mark A. Hlatky, Philip Greenland et al. Circulation
  22. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease (2006)
    James B. Meigs, Peter W.F. Wilson et al. The Journal of Clinical Endocrinology & Metabolism
  23. Impact of Obesity on Plasma Natriuretic Peptide Levels (2004)
    Thomas J. Wang, Martin G. Larson et al. Circulation
  24. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. (2007)
    Peter W.F. Wilson et al. PubMed
  25. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency (1999)
    Bruce F. Culleton, Martin G. Larson et al. Kidney International
  26. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study (2001)
    Natalia S. Rost, Philip A. Wolf et al. Stroke
  27. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction (2003)
    Ramachandran S. Vasan, Lisa Sullivan et al. Circulation
  28. Carbohydrate Nutrition, Insulin Resistance, and the Prevalence of the Metabolic Syndrome in the Framingham Offspring Cohort (2004)
    Nicola M. McKeown, James B. Meigs et al. Diabetes Care
  29. Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy (2001)
    Colleen Hadigan, Colleen Corcoran et al. Clinical Infectious Diseases
  30. Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes (2008)
    James B. Meigs, Peter Shrader et al. New England Journal of Medicine
  31. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study (1997)
    Leena I. Kauppila, Joseph F. Polak et al. Atherosclerosis
  32. C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study (2004)
    Martin K. Rutter, James B. Meigs et al. Circulation
  33. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis (2010)
    Deepak L. Bhatt, Kim A. Eagle et al. JAMA
  34. Abdominal Aortic Calcific Deposits Are an Important Predictor of Vascular Morbidity and Mortality (2001)
    Peter W.F. Wilson, Leena I. Kauppila et al. Circulation
  35. Clustering of Metabolic Factors and Coronary Heart Disease (1999)
    Peter W.F. Wilson, William B. Kannel et al. Archives of Internal Medicine
  36. Hip Fracture and the Use of Estrogens in Postmenopausal Women (1988)
    Douglas P. Kiel, David T. Felson et al. Obstetrical & Gynecological Survey
  37. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort (2001)
    Paul F. Jacques, Andrew G. Bostom et al. American Journal of Clinical Nutrition
  38. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. (1988)
    Peter W.F. Wilson, R D Abbott et al. Arteriosclerosis An Official Journal of the American Heart Association Inc
  39. Low density lipoprotein particle size and coronary artery disease. (1992)
    Hannia Campos, Jacques Genest et al. Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  40. Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50 (1985)
    Peter W.F. Wilson, Robert J. Garrison et al. New England Journal of Medicine
  41. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death (2015)
    Matthew A. Cavender, Philippe Gabríel Steg et al. Circulation
  42. Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults (2019)
    Sridharan Raghavan, Jason L. Vassy et al. Journal of the American Heart Association
  43. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019)
    Ann C. Skulas‐Ray, Peter W.F. Wilson et al. Circulation
  44. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease (2023)
    Aniruddh P. Patel, Minxian Wang et al. Nature Medicine

Immediate Impact

11 from Science/Nature 144 standout
Sub-graph 1 of 21

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
2020 Standout
1 intermediate paper

Works of Peter W.F. Wilson being referenced

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
2010 Standout
One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis
2007 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Peter W.F. Wilson 29024 34252 30320 632 107.0k
Paul M. Ridker 23448 37641 40769 811 127.8k
William B. Kannel 25140 69673 22477 475 125.2k
Daniel Levy 18947 88384 24628 807 138.9k
Stuart Pocock 15196 34883 31770 569 137.2k
Josef Coresh 16406 29995 15647 936 112.1k
Ramachandran S. Vasan 15602 55741 13453 941 105.1k
Nader Rifai 16018 20862 20465 450 75.0k
Charles H. Hennekens 17141 18066 12212 577 83.9k
Andrew S. Levey 13235 30240 17388 503 121.9k
Scott M. Grundy 58772 38940 50319 582 156.3k

All Works

Loading papers...

Rankless by CCL
2026